TSE:9267Consumer Retailing
Genky DrugStores Q2 Net Margin At 3.7% Reinforces Bullish Earnings Narrative
Genky DrugStores (TSE:9267) has reported Q2 2026 results with revenue of ¥53.2 billion and basic EPS of ¥65.10, set against trailing twelve month EPS of ¥257.06 and net income of ¥7.8 billion. The company has seen revenue move from ¥48.6 billion in Q3 2025 to ¥56.0 billion in Q1 2026 and ¥53.2 billion in Q2 2026, while quarterly EPS has ranged from ¥52.80 to ¥72.15 over the same period. This keeps the focus firmly on how efficiently those sales are translating into profit. With net profit...